FDA seeks feedback on ways to bring manufacturing back to the US
Regulatory NewsJoanne S. Eglovitch
APIsBiologics/ biosimilars/ vaccinesGenericsManufacturingPharmaceuticalsPublic healthRegulatory Intelligence/PolicyRegulatory strategyUnited StatesUS Food and Drug Administration (FDA)